Exhibit 1.1
EXECUTION
COPY
13,000,000 Shares
American Equity Investment Life Holding
Company
Common Stock
($1.00 Par Value)
UNDERWRITING
AGREEMENT
December 14, 2005
Raymond James &
Associates, Inc.
As Representative of the
Several
Underwriters
c/o Raymond James &
Associates, Inc.
880 Carillon Parkway
St. Petersburg, Florida 33716
Ladies and Gentlemen:
American Equity Investment Life
Holding Company, an Iowa corporation (the “Company”),
proposes to sell to the several underwriters (the
“Underwriters”) named in Schedule I hereto for
whom you are acting as representative (the
“Representative”) an aggregate of 13,000,000 shares of
the Company’s Common Stock, $1.00 par value (the “Firm
Shares”). The respective amounts of the Firm Shares to
be so purchased by the several Underwriters are set forth opposite
their names in Schedule I hereto. The Company also
proposes to sell at the Underwriters’ option an aggregate of
up to 1,950,000 additional shares of the Company’s Common
Stock (the “Option Shares”) as set forth below.
The Company’s Common Stock, $1.00 par value, is hereinafter
referred to as the “Common Stock.”
As the Representative, you have
advised the Company (a) that you are authorized to enter into
this Agreement on behalf of the several Underwriters, and
(b) that the several Underwriters are willing, acting, subject
to Section 9, severally and not jointly, to purchase the
numbers of Firm Shares set forth opposite their respective names in
Schedule I, plus their pro rata portion of the Option Shares
if you elect to exercise the over-allotment option in whole or in
part for the accounts
1
of the several Underwriters. The Firm
Shares and the Option Shares (to the extent the aforementioned
option is exercised) are herein collectively called the
“Shares.”
In consideration of the mutual
agreements contained herein and of the interests of the parties in
the transactions contemplated hereby, the parties hereto agree as
follows:
1.
REPRESENTATIONS AND WARRANTIES OF
THE COMPANY .
The Company represents and warrants
to each of the Underwriters as follows:
(a)
A registration statement on
Form S-3 (File No. 333-129694) with respect to the
securities (the “Shelf Securities”), including the
Shares, to be issued from time to time by the Company and certain
of its subsidiaries has been prepared by the Company and such
subsidiaries in conformity in all material respects with the
requirements of the Securities Act of 1933, as amended (the
“Act”), and the rules and regulations (the
“Rules and Regulations”) of the Securities and
Exchange Commission (the “Commission”) thereunder and
has been filed with the Commission. The Company and the
transactions contemplated by this Agreement meet the requirements
and comply in all material respects with the conditions for the use
of Form S-3. Copies of such registration statement,
including any amendments thereto, the preliminary prospectuses
(meeting in all material respects the requirements of the
Rules and Regulations) contained therein and the exhibits,
financial statements and schedules, as finally amended and revised,
have heretofore been delivered by the Company or made available to
you. Such registration statement, as amended at the time of
effectiveness thereof, together with any registration statement
filed by the Company pursuant to Rule 462 (b) of the Act,
is herein referred to as the “Registration Statement,”
which shall be deemed to include all information omitted therefrom
in reliance upon Rule 430A or Rule 430B and contained in
the Prospectus referred to below, and has become effective under
the Act. No post-effective amendment to the Registration Statement
has been filed as of the date of this Agreement. The related
prospectus covering the Shelf Securities dated November 22,
2005 is hereinafter referred to as the “Basic
Prospectus.” “Prospectus” means the Basic
Prospectus, as supplemented by the prospectus supplement
specifically relating to the Shares in the form first used to
confirm sales of the Shares (or in the form first made available to
the Underwriters by the Company to meet requests of purchasers
pursuant to Rule 173 under the Act), and “Preliminary
Prospectus” means any preliminary form of the
Prospectus. For purposes of this Agreement, “free
writing prospectus” has the meaning ascribed to it in
Rule 405 under the Act, and “Time of Sale
Information” means the Preliminary Prospectus together with
the free writing prospectuses, if any, each identified in
Schedule II hereto and the pricing information set forth in
the Schedule II hereto. In addition, you have advised us
that the Underwriters have or will orally provide the pricing
information set forth in Schedule II hereto to prospective
purchasers prior to confirming sales. Any reference herein to
the Registration Statement, the Basic Prospectus, any Preliminary
Prospectus, the Prospectus or the Time of Sale Information or to
any amendment or supplement to any of the foregoing documents shall
be deemed to refer to and include any documents incorporated by
reference therein, and, in the case of any reference herein to any
Prospectus, also shall be deemed to include any documents
incorporated by reference therein, and any supplements or
amendments
2
thereto, filed with the Commission after the
date of filing of the Prospectus under Rules 424(b), 430A or
430B, and prior to the termination of the offering of the Shares by
the Underwriters.
(b)
The Company has been duly
incorporated and is validly existing as a corporation in good
standing under the laws of the State of Iowa, with the corporate
power and authority to own or lease its properties and conduct its
business as described in the Registration Statement, the Time of
Sale Information and the Prospectus and to enter into and perform
its obligations under this Agreement; each of the direct and
indirect subsidiaries of the Company (each, a
“Subsidiary” and collectively, the
“Subsidiaries”), has been duly incorporated or
organized and is validly existing and in good standing under the
laws of the jurisdiction of its incorporation or organization, with
the corporate or other power and authority to own or lease its
properties and conduct its business as described in the
Registration Statement, the Time of Sale Information and the
Prospectus; the Company and each of the Subsidiaries are duly
qualified to transact business in all jurisdictions in which the
conduct of their business requires such qualification, except to
the extent that the failure to be so qualified would not result in
a Material Adverse Change (as defined herein).
(c)
The outstanding shares of capital
stock of each of the Subsidiaries have been duly authorized and
validly issued, are fully paid and non-assessable and are owned by
the Company or another Subsidiary free and clear of all liens,
encumbrances and equities and claims, except those securing
obligations under the Amended and Restated Credit Agreement dated
September 22, 2004 among the Company, West Des Moines State
Bank, LaSalle Bank and U.S. Bank National Association, as agent
(the “Credit Agreement”) or those that are immaterial
to the Company and the Subsidiaries taken as a whole; and, except
as disclosed in the Registration Statement, the Time of Sale
Information and the Prospectus, no options, warrants or other
rights to purchase, agreements or other obligations to issue or
other rights to convert any obligations into or exchange any
securities for shares of capital stock of or ownership interests in
the Subsidiaries are outstanding.
(d)
The outstanding shares of capital
stock of the Company have been duly authorized and validly issued
and are fully paid and non-assessable; none of the outstanding
shares of capital stock issued by the Company was issued in
violation of any preemptive or similar rights of any stockholder of
the Company; the Shares have been duly authorized and when issued
and paid for as contemplated herein will be validly issued, fully
paid and non-assessable; and no preemptive rights of stockholders
exist with respect to any of the Shares or the issue and sale
thereof. Neither the filing of the Registration Statement nor
the offering or sale of the Shares as contemplated by this
Agreement gives rise to any rights, other than those which have
been waived or satisfied or the violation of which would not have a
material adverse effect on the Company and the Subsidiaries taken
as a whole, for or relating to the registration of any shares of
Common Stock.
(e)
The execution and delivery of, and
the performance by the Company of its obligations under, this
Agreement have been duly authorized by all necessary corporate
action on
3
the part of the Company, and this Agreement has
been duly executed and delivered by the Company.
(f)
The consolidated capitalization of
the Company set forth under the caption
“Capitalization” in the Registration Statement, the
Time of Sale Information and the Prospectus is true and correct as
of the date set forth therein; all of the Shares conform to the
description thereof contained in the Registration Statement, the
Time of Sale Information and the Prospectus in all material
respects; the form of certificate for the Shares conforms to the
corporate law of the jurisdiction of the Company’s
incorporation in all material respects.
(g)
Except as described in or
contemplated by the Registration Statement, the Time of Sale
Information and the Prospectus, there are no outstanding securities
of the Company convertible or exchangeable into or evidencing the
right to purchase or subscribe for any shares of capital stock of
the Company and there are no outstanding or authorized options,
warrants or rights of any character obligating the Company to issue
any shares of its capital stock or any securities convertible or
exchangeable into or evidencing the right to purchase or subscribe
for any shares of such stock.
(h)
The Commission has not issued an
order preventing or suspending the use of any Prospectus relating
to the proposed offering of the Shares nor instituted proceedings
for that purpose. No order suspending the effectiveness of
the Registration Statement has been issued by the Commission and no
proceedings for that purpose or pursuant to Section 8A of the
Act against the Company or relating to the offering of the Shares
has been taken, or to the best knowledge of the Company,
contemplated or threatened by the Commission. The
Registration Statement contains, and the Prospectus and any
amendments or supplements thereto will contain, all statements
which are required to be stated therein by, and will conform in all
material respects to, the requirements of the Act and the
Rules and Regulations. The documents incorporated, or to
be incorporated, by reference in the Time of Sale Information or
the Prospectus, at the time filed with the Commission conformed or
will conform, in all material respects to the requirements of the
Securities Exchange Act of 1934 (“Exchange Act”) or the
Act, as applicable, and the rules and regulations of the
Commission thereunder. The Registration Statement and any
amendment thereto did not contain as of the effective date thereof,
do not contain, and will not contain, any untrue statement of a
material fact and did not omit as of the effective date thereof, do
not omit and will not omit, to state any material fact required to
be stated therein or necessary to make the statements therein not
misleading. The Time of Sale Information and any amendments
or supplements thereto does not contain, and at the time of sale of
the Shares in connection with the offering contemplated hereby and
at the Closing Date (as defined herein) will not contain, any
untrue statement of a material fact and does not omit, and at the
time of sale of the Shares in connection with the offering
contemplated hereby and at the Closing Date will not omit, to state
any material fact required to be stated therein or necessary
in
4
order to make the statements therein, in the
light of the circumstances under which they were made, not
misleading. The Prospectus and any amendments and supplements
thereto do not contain, and will not contain, any untrue statement
of material fact; and do not omit, and will not omit, to state any
material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that
the Company makes no representations or warranties as to
information contained in or omitted from the Registration
Statement, the Time of Sale Information or the Prospectus, or any
such amendment or supplement, in reliance upon, and in conformity
with, written information furnished to the Company by or on behalf
of any Underwriter through the Representative, specifically for use
therein, it being understood and agreed that the only such
information is that described in Section 13 herein.
(i)
The Company is not an
“ineligible issuer” in connection with the offering
contemplated hereby pursuant to Rules 164, 405 and 433 under
the Act; any free writing prospectus that the Company is required
to file pursuant to Rule 433(d) under the Act has been,
or will be, filed with the Commission in accordance with the
requirements of the Act and the Rules and Regulations; each
free writing prospectus that the Company has filed, or is required
to file, pursuant to Rule 433(d) under the Act or that
was prepared by or on behalf of or used by the Company complies or
will comply in all material respects with the requirements of the
Act and the Rules and Regulations; except for the free writing
prospectuses, if any, identified in Schedule II hereto, and
electronic roadshows, if any, furnished to you before first use,
the Company has not prepared, used or referred to, and will not,
without your prior written consent, prepare, use or refer to, any
free writing prospectus.
(j)
The consolidated financial
statements of the Company and the Subsidiaries, together with
related notes and schedules, incorporated by reference in the
Registration Statement, the Time of Sale Information and the
Prospectus, present fairly in all material respects the financial
position and the results of operations and cash flows of the
Company and its consolidated Subsidiaries, at the indicated dates
and for the indicated periods; such financial statements and
related notes and schedules have been prepared in accordance with
generally accepted accounting principles in the United States,
consistently applied throughout the periods involved, except as
disclosed therein, and all adjustments necessary for a fair
presentation of results for such periods have been made; the
selected consolidated financial and other data of the Company and
the Subsidiaries included or incorporated by reference in the
Registration Statement, the Time of Sale Information and the
Prospectus presents fairly in all material respects the information
shown therein and such data has been compiled on a basis consistent
with that of the audited consolidated financial statements
incorporated by reference in the Registration Statement, the Time
of Sale Information and the Prospectus or with statutory accounting
principles or practices required or permitted by the National
Association of Insurance Commissioners and by the appropriate
insurance department of the jurisdiction of each Insurance
Subsidiary (as defined below) (“SAP”), as
applicable.
(k)
Each of Ernst & Young LLP,
who have certified, and KPMG LLP, who have reviewed, certain of the
financial statements incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, are
independent public accountants as required by the Act and the
Rules and Regulations and is not in violation of the
auditor
5
independence requirements of the Sarbanes-Oxley
Act of 2002, as amended, and the rules and regulations
promulgated by the Commission thereunder (the “Sarbanes-Oxley
Act”).
(l)
Except as disclosed in the
Registration Statement, the Time of Sale Information and the
Prospectus, there is no action, suit, claim, proceeding or labor
dispute pending or, to the best knowledge of the Company,
threatened against the Company or any of the Subsidiaries before
any court or administrative agency or otherwise which, if
determined adversely to the Company or any of its Subsidiaries,
would reasonably be expected to result in a material adverse change
in the earnings, business, properties, assets, operations,
condition (financial or otherwise) or prospects of the Company and
the Subsidiaries taken as a whole (a “Material Adverse
Change”), or prevent the consummation of the transactions
contemplated hereby.
(m)
The Company and the Subsidiaries
have good and marketable title to all real property owned by them
and good title to all other properties owned by them, subject to no
lien, mortgage, pledge, charge or encumbrance of any kind, except
those securing obligations under the Credit Agreement or reflected
in the consolidated financial statements hereinabove described or
described in the Registration Statement, the Time of Sale
Information and the Prospectus or which do not materially affect
the value of such property and do not interfere with the use made
of such property; the Company and the Subsidiaries occupy their
leased properties under valid and binding leases.
(n)
The Company and the Subsidiaries
have filed all Federal, State, local and foreign tax returns which
have been required to be filed and have paid all taxes indicated by
such returns and all assessments received by them or any of them to
the extent that such taxes have become due, except to the extent
that any failure to so file or pay would not reasonably be expected
to result in a Material Adverse Change; all tax liabilities have
been adequately provided for in the financial statements of the
Company, and the Company does not know of any actual or proposed
additional material tax assessments.
(o)
Since the respective dates as of
which information is given in the Registration Statement, the Time
of Sale Information and the Prospectus, except as otherwise stated
therein, there has not been any Material Adverse Change or, to the
best knowledge of the Company, any development involving a
prospective Material Adverse Change, whether or not arising in the
ordinary course of business, and there has not been any material
transaction entered into or any material transaction that is
probable of being entered into by the Company or any of the
Subsidiaries, other than transactions in the ordinary course of
business and transactions described in the Registration Statement,
the Time of Sale Information and the Prospectus, which are material
to the Company and the Subsidiaries considered as one enterprise;
neither the Company nor any of the Subsidiaries has any contingent
obligations which are material to the Company and the Subsidiaries
taken as a whole but which are not disclosed in the Company’s
financial statements that are incorporated by reference in the
Registration Statement, the Time of Sale Information and the
Prospectus.
6
(p)
Neither the Company nor any of the
Subsidiaries is or, with the giving of notice or lapse of time or
both, will be, in violation of or in default under (i) its
certificate of incorporation or bylaws or similar organizational
documents or (ii) any indenture, mortgage, deed of trust,
lease, contract or other agreement or instrument to which any of
them is a party or to which any of them or any of their respective
properties is bound (collectively, “Contracts”) and,
solely with respect to this clause (ii), which violation or default
would result in a Material Adverse Change.
(q)
The execution and delivery of this
Agreement by the Company, the issuance and sale of the Shares to
the Underwriters by the Company pursuant to this Agreement and the
consummation of the transactions contemplated in this Agreement and
the fulfillment of the terms hereof by the Company will not
conflict with or result in a breach of any of the terms or
provisions of, or constitute a default under, (i) any Contract
(including, without limitation, the Credit Agreement),
(ii) the certificate of incorporation or bylaws of the
Company, or (iii) any law, order, rule, regulation, judgment,
order, writ or decree of any court applicable to the Company or any
Subsidiary or of any government, regulatory body or administrative
agency or other governmental body having jurisdiction over the
Company or any Subsidiary, except, in the case of clauses
(i) and (iii) to the extent that any such conflict,
breach or default would not reasonably be expected to result in a
Material Adverse Change.
(r)
Each approval, consent, order,
authorization, designation, declaration or filing by or with any
regulatory, administrative or other governmental body necessary in
connection with the execution and delivery by the Company of this
Agreement, the issuance and sale of the Shares to the Underwriters
by the Company pursuant to this Agreement and the consummation of
the transactions contemplated in this Agreement has been obtained
or made and is in full force and effect, except for such additional
steps as may be necessary to qualify the Shares for public offering
by the Underwriters under state securities or “Blue
Sky” laws.
(s)
Each of the Company and each
Subsidiary that is engaged in the business of insurance or
reinsurance (collectively, the “Insurance
Subsidiaries”) is in compliance with the requirements of the
insurance laws and regulations of its respective jurisdiction of
organization or incorporation, as the case may be, and the
insurance laws and regulations of other jurisdictions which are
applicable to it, and has filed all notices, reports, documents or
other information required to be filed thereunder, in each case,
with such exceptions as would not reasonably be expected to result
in a Material Adverse Change; neither the Company nor any Insurance
Subsidiary has received any notification from any insurance
regulatory authority to the effect that any additional
authorization, approval, order, consent, license, certificate,
permit, registration or qualification (“Approvals”) is
needed to be obtained by the Company or any of the Insurance
Subsidiaries in any case where it could be reasonably expected that
obtaining such Approvals or the failure to obtain such Approvals
would result in a Material Adverse Change.
(t)
Each of the Insurance Subsidiaries
holds such insurance licenses, certificates and permits from
governmental authorities (including, without limitation, from the
insurance
7
regulatory agencies of the various jurisdictions
where it conducts business (the “Insurance Licenses”))
as are material to the conduct of its business as described in the
Registration Statement, the Time of Sale Information and the
Prospectus; the Company and each Insurance Subsidiary have
fulfilled and performed all obligations necessary to maintain such
Insurance Licenses; there is no pending or, to the best knowledge
of the Company, threatened action, suit, proceeding or
investigation that would reasonably be expected to result in the
revocation, termination or suspension of any Insurance License that
would reasonably be expected to, individually or in the aggregate,
result in a Material Adverse Change; no insurance regulatory agency
or body has issued, or commenced any proceeding for the issuance
of, any order or decree impairing, restricting or prohibiting the
payment of dividends by any Insurance Subsidiary to its
parent.
(u)
All reinsurance treaties and
arrangements to which any Insurance Subsidiary is a party are in
full force and effect and no Insurance Subsidiary is in violation
of, or in default in the performance, observance or fulfillment of,
any obligation, agreement, covenant or condition contained therein,
except where the failure to be in full force and effect or where
such violation or default would not, individually or in the
aggregate, be reasonably expected to result in a Material Adverse
Change. No Insurance Subsidiary has received any notice from any of
the other parties to such treaties, contracts or agreements that
such other party intends not to perform such treaty and, to the
best knowledge of the Company, none of the other parties to such
treaties or arrangements will be unable to perform such treaty or
arrangement except to the extent adequately and properly reserved
for in the audited consolidated financial statements of the Company
included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, except
where such nonperformance would not reasonably be expected to,
individually or in the aggregate, result in a Material Adverse
Change.
(v)
The statutory financial statements
of the Insurance Subsidiaries, from which certain data included in
the Registration Statement, the Time of Sale Information and the
Prospectus have been derived, have been prepared, for each relevant
period, in conformity with SAP applied on a consistent basis
throughout the periods involved, except (1) as may otherwise
be indicated therein or in the notes thereto and (2) in the
case of any such financial statements for periods less than a full
year, for any normal year-end adjustments, and present fairly in
all material respects the statutory financial position of the
Insurance Subsidiaries as of the dates thereof, and the statutory
basis results of operations of the Insurance Subsidiaries for the
periods covered thereby.
(w)
The Company and each of the
Subsidiaries hold all material licenses, certificates and permits
from governmental authorities which are necessary to the conduct of
their businesses.
(x)
The Company and the Subsidiaries
each own or possess, or can acquire on reasonable terms, adequate
patents, patent rights, trademarks, trade names, service marks,
service names, copyrights, license rights, know-how (including
trade secrets and other unpatented and unpatentable proprietary or
confidential information, systems or procedures) and other
intellectual property rights (“Intellectual Property”)
necessary to carry on their business in all material
respects;
8
none of the Company or any of the Subsidiaries
has received notice of any infringement of or conflict with, any
Intellectual Property of any other person or entity, except to the
extent that such infringement or conflict if determined adversely
to the Company or such Subsidiary would not reasonably be expected
to result in a Material Adverse Change.
(y)
Neither the Company nor, to the best
of the Company’s knowledge, any of its affiliates, has taken
or may take, directly or indirectly, any action designed to cause
or result in, or which has constituted or which might reasonably be
expected to constitute, the stabilization or manipulation of the
price of the shares of Common Stock to facilitate the sale or
resale of the Shares.
(z)
The Company is not, and after giving
effect to the offering and sale of the Shares contemplated
hereunder and the application of the net proceeds from such sale as
described in the Registration Statement, the Time of Sale
Information and the Prospectus will not be, required to register as
an “investment company” as such term is defined in the
Investment Company Act of 1940, as amended (the “Investment
Company Act”).
(aa)
Except as disclosed in the
Registration Statement, the Time of Sale Information and the
Prospectus, the Company and each of the Subsidiaries maintain a
system of internal accounting controls sufficient to provide
reasonable assurances that (A) transactions are executed in
accordance with management’s general or specific
authorization; (B) transactions are recorded as necessary to
permit preparation of financial statements in conformity with
generally accepted accounting principles and to maintain
accountability for assets; (C) access to assets is permitted
only in accordance with management’s general or specific
authorization; and (D) the recorded accountability for assets
is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any
differences.
(bb)
The Company and the Subsidiaries
comply with all Environmental Laws (as defined below), except to
the extent that failure to comply with such Environmental Laws
would not, individually or in the aggregate, be reasonably expected
to result in a Material Adverse Change; none of the Company or any
of the Subsidiaries is the subject of any pending or, to the best
knowledge of the Company, threatened federal, state or local
investigation evaluating whether any remedial action by the Company
or any of the Subsidiaries is needed to respond to a release of any
Hazardous Materials (as defined below) into the environment
resulting from the Company’s or any of the
Subsidiaries’ business operations or ownership or possession
of any of their properties or assets, or is in contravention of any
Environmental Law that could reasonably be expected, individually
or in the aggregate, to result in any Material Adverse Change; none
of the Company or any of the Subsidiaries has received any notice
or claim, nor are there pending or, to the best knowledge of the
Company, threatened lawsuits against them, with respect to
violations of an Environmental Law or in connection with any
release of any Hazardous Material into the environment that could
reasonably be expected in the aggregate to result in a Material
Adverse Change; as used herein, “Environmental Laws”
means any federal, state or local law or regulation applicable to
the Company’s or any of the Subsidiaries’ business
operation or ownership or
9
possession of any of their properties or assets
relating to environmental matters, and “Hazardous
Materials” means those substances that are regulated by or
form the basis of liability under any Environmental
Laws.
(cc)
The Company and each of its
Subsidiaries carry, or are covered by, insurance in such amounts
and covering such risks as is generally deemed adequate for the
conduct of their respective businesses as presently conducted and
the value of their respective properties and as is customary for
companies engaged in similar businesses.
(dd)
The Company and each Subsidiary are
in compliance in all material respects with all presently
applicable provisions of the Employee Retirement Income Security
Act of 1974, as amended, including the regulations and published
interpretations thereunder (“ERISA”); no
“reportable event” (as defined in ERISA) has occurred
with respect to any “pension plan” (as defined in
ERISA) for which the Company or any Subsidiary would have any
material liability; neither the Company nor any Subsidiary has
incurred or expects to incur any material liability under
(i) Title IV of ERISA with respect to termination of, or
withdrawal from, any “pension plan” or
(ii) Sections 412 or 4971 of the Internal Revenue Code of
1986, as amended, including the regulations and published
interpretations thereunder (the “Code”); and each
“pension plan” for which the Company or any Subsidiary
would have any liability that is intended to be qualified under
Section 401(a) of the Code is so qualified in all
material respects and nothing has occurred, whether by action or by
failure to act, which would cause the loss of such
qualification
(ee)
The Company is subject to and in
full compliance in all material respects with the reporting
requirements of Section 13 or Section 15(d) of the
Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and the rules and regulations of the Commission
thereunder.
(ff)
There is and has been no failure on
the part of the Company or, to the best knowledge of the Company,
any of the Company’s directors or officers, in their
capacities as such, to comply in all material respects with any
provision of the Sarbanes-Oxley Act, including Section 402
related to loans, Section 404 related to internal control over
financial reporting and Sections 302 and 906 related to
certifications.
(gg)
The Shares have been approved for
listing subject to notice of issuance on the New York Stock
Exchange.
(hh)
Except as disclosed in the
Registration Statement, the Time of Sale Information and the
Prospectus, neither the Company nor any of its Subsidiaries is
aware of (i) any material weakness in its internal control
over financial reporting or (ii) change in internal control
over financial reporting that has materially affected, or is
reasonably likely to materially affect, the Company’s
internal control over financial reporting.
10
2.
PURCHASE, SALE AND DELIVERY OF
THE FIRM SHARES .
(a)
On the basis of the representations,
warranties and covenants herein contained, and subject to the
conditions herein set forth, the Company agrees to sell to the
Underwriters and each Underwriter agrees, subject to
Section 9, severally and not jointly, to purchase, at a price
of $10.991 per share, the number of Firm Shares set forth opposite
the name of each Underwriter in Schedule I hereof, subject to
adjustments in accordance with Section 9 hereof.
(b)
Payment for the Firm Shares to be
sold hereunder is to be made in Federal (same day) funds against
delivery of certificates therefor to the Representative for the
several accounts of the Underwriters. Such payment and
delivery are to be made through the facilities of The Depository
Trust Company, New York, New York at 10:00 a.m., New York
time, on December 20, 2005 or at such other time and date not
later than five business days thereafter as you and the Company
shall agree upon, such time and date being herein referred to as
the “Closing Date.” (As used herein,
“business day” means a day on which the New York Stock
Exchange is open for trading and on which banks in New York are
open for business and are not permitted by law or executive order
to be closed.)
(c)
In addition, on the basis of the
representations and warranties herein contained and subject to the
terms and conditions herein set forth, the Company hereby grants an
option to the several Underwriters to purchase the Option Shares at
the price per share as set forth in the first paragraph of this
Section 2. The option granted hereby may be exercised in
whole or in part by giving written notice (i) at any time
before the Closing Date and (ii) at any time and from time to
time within 30 days after the date of this Agreement, by you, as
Representative of the several Underwriters, to the Company setting
forth the number of Option Shares as to which the several
Underwriters are exercising the option and the time and date at
which such certificates are to be delivered. The time and
date at which certificates for Option Shares are to be delivered
shall be determined by the Representative but shall not be earlier
than three nor later than 10 full business days after the exercise
of such option, nor in any event prior to the Closing Date (such
time and date being herein referred to as the “Option Closing
Date”). If the date of exercise of the option is three
or more days before the Closing Date, the notice of exercise shall
set the Closing Date as the Option Closing Date. The number
of Option Shares to be purchased by each Underwriter shall be in
the same proportion to the total number of Option Shares being
purchased as the number of Firm Shares being purchased by such
Underwriter bears to the total number of Firm Shares, adjusted by
you in such manner as to avoid fractional shares. The option
with respect to the Option Shares granted hereunder may be
exercised only to cover over-allotments in the sale of the Firm
Shares by the Underwriters. You, as Representative of the
several Underwriters, may cancel such option at any time prior to
its expiration by giving written notice of such cancellation to the
Company. To the extent, if any, that the option is exercised,
payment for the Option Shares shall be made on the Option Closing
Date in Federal (same day funds) through the facilities of The
Depository Trust Company in New York, New York drawn to the order
of the Company.
11
3.
OFFERING BY THE UNDERWRITERS;
COVENANTS OF THE UNDERWRITERS .
(a)
It is understood that the several
Underwriters are to make a public offering of the Firm Shares as
soon as the Representative deems it advisable to do so. The
Firm Shares are to be initially offered to the public at the
initial public offering price set forth in the Prospectus.
The Representative may from time to time thereafter change the
public offering price and other selling terms.
(b)
It is further understood that you
will act as the Representative for the Underwriters in the offering
and sale of the Shares in accordance with a Master Agreement Among
Underwriters entered into by you and the several other
Underwriters.
(c)
Each Underwriter severally covenants
with the Company that:
(i)
It will not take any action that
would result in the Company being required to file with the
Commission under Rule 433(d) under the Act a free writing
prospectus prepared by or on behalf of such Underwriter that
otherwise would not be required to be filed by the Company
thereunder, but for the action of such Underwriter.
(ii)
It will furnish to the Company with
a copy of each proposed free writing prospectus to be prepared by
or on behalf of such Underwriter before its first use and will not
use any free writing prospectus to which the Company reasonably
objects.
4.
COVENANTS OF THE
COMPANY .
The Company covenants and agrees
with the several Underwriters that:
(a)
The Company will (A) prepare
and timely file with the Commission under Rule 424(b) and
Rule 430A or 430B of the Rules and Regulations a
Prospectus in a form approved by the Representative containing
information previously omitted at the time of effectiveness of the
Registration Statement in reliance on Rule 430A or 430B of the
Rules and Regulations, (B) prior to the expiration of the
period during which the delivery of a Prospectus (or in lieu
thereof the notice referred to under Rule 173(a) under
the Act) is required under the Act, not file any amendment to the
Registration Statement or distribute any amendment or supplement to
the Time of Sale Information or the Prospectus or document
incorporated by reference therein of which the Representative shall
not previously have been advised and furnished with a copy or to
which the Representative shall have reasonably objected in writing
or which is not in compliance with the Rules and Regulations,
(C) not prepare, use or refer to any free writing prospectus
to be prepared by or on behalf of, or used by, or referred to by
the Company of which the Representative shall not previously have
been advised and furnished with a copy or to which the
Representative shall have reasonably objected in writing or which
is not in compliance with the Rules and Regulations,
(D) not take any action that would result in an Underwriter or
the Company being required to file with the Commission pursuant to
Rule 433(d) under the Act a free writing prospectus
prepared by or on behalf of such Underwriter that such Underwriter
otherwise would not have been required to file
12
thereunder and (E) subject to clauses
(C) and (D) above, file any free writing prospectus with
the Commission to the extent required by Rule 433 under the
Act.
(b)
The Company will advise the
Representative promptly (A) when any post-effective amendment
to the Registration Statement shall have become effective,
(B) of receipt of any comments from the Commission,
(C) of any request of the Commission for amendment of the
Registration Statement or for supplement to the Time of Sale
Information or the Prospectus or for any additional information,
and (D) of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement or the
use of the Time of Sale Information or the Prospectus or of the
institution of any proceedings for that purpose. The Company
will use its best efforts to prevent the issuance of any such stop
order preventing or suspending the use of the Time of Sale
Information or the Prospectus and to obtain as soon as possible the
lifting thereof, if issued.
(c)
The Company will cooperate with the
Representative in endeavoring to qualify the Shares for sale under
the securities laws of such jurisdictions as the Representative may
reasonably have designated in writing and will make such
applications, file such documents, and furnish such information as
may be reasonably required for that purpose, provided the Company
shall not be required to qualify as a foreign corporation or to
file a general consent to service of process in any jurisdiction
where it is not now so qualified or required to file such a consent
or to subject itself to taxation in respect of doing business in
any jurisdiction in which it is not otherwise so subject. The
Company will, from time to time, prepare and file such statements,
reports, and other documents, as are or may be required to continue
such qualifications in effect for so long a period as the
Representative may reasonably request for distribution of the
Shares.
(d)
The Company will deliver to, or upon
the order of, the Representative, from time to time, as many copies
of any Time of Sale Information as the Representative may
reasonably request. The Company will deliver to, or upon the
order of, the Representative during the period when delivery of a
Prospectus (or in lieu thereof the notice referred to under
Rule 173(a) under the Act) is required under the Act, as
many copies of the Prospectus in final form, or as thereafter
amended or supplemented, as the Representative may reasonably
request. The Company will deliver to the Representative at or
before the Closing Date, signed (but not original) copies of the
Registration Statement and all amendments thereto including all
exhibits filed therewith, and will deliver to the Representative
such number of copies of the Registration Statement (including such
number of copies of the exhibits filed therewith that may
reasonably be requested), including documents incorporated by
reference therein, and of all amendments thereto, as the
Representative may reasonably request.
(e)
The Company will comply with the Act
and the Rules and Regulations, and the Exchange Act, and the
rules and regulations of the Commission thereunder, so as to
permit the completion of the distribution of the Shares as
contemplated in this Agreement and the Prospectus. If during
the period in which a prospectus (or in lieu thereof the notice
referred to in Rule 173(a) under the Act) is required by
law to be delivered by an Underwriter or dealer, any event shall
occur
13
as a result of which, in the judgment of the
Company or in the reasonable opinion of the Underwriters, it
becomes necessary to amend or supplement the Prospectus in order to
make the statements therein, in the light of the circumstances
existing at the time the Prospectus (or in lieu thereof the notice
referred to in Rule 173(a) under the Act) is delivered to
a purchaser, not misleading, or, if it is necessary at any time to
amend or supplement the Prospectus to comply with any law, the
Company promptly will either (i) prepare, file with the
Commission and furnish to the Underwriters or any dealers an
appropriate amendment to the Registration Statement or supplement
to the Prospectus or (ii) prepare and file with the Commission
an appropriate filing under the Exchange Act which shall be
incorporated by reference in the Prospectus so that the Prospectus
as so amended or supplemented will not, in the light of the
circumstances when it (or in lieu thereof the notice referred to in
Rule 173(a) under the Act) is so delivered, be
misleading, or so that the Prospectus will comply with the
law.
(f)
If the Time of Sale Information is
being used to solicit offers to buy the Shares at a time when the
Prospectus is not yet available to prospective purchasers and any
event shall occur as a result of which, in the judgment of the
Company or in the reasonable opinion of the Underwriters, it
becomes necessary to amend or supplement the Time of Sale
Information in order to make the statements therein, in the light
of the circumstances, not misleading, or to make the statements
therein not conflict with the information contained in the
Registration Statement then on file, or if it is necessary at any
time to amend or supplement the Time of Sale Information to comply
with any law, the Company promptly will either (i) prepare,
file with the Commission (if required) and furnish to the
Underwriters and any dealers an appropriate amendment or supplement
to the Time of Sale Information or (ii) prepare and file with
the Commission an appropriate filing under the Exchange Act which
shall be incorporated by reference in the Time of Sale Information
so that the Time of Sale Information as so amended or supplemented
will not, in the light of the circumstances, be misleading or
conflict with the Registration Statement then on file, or so that
the Time of Sale Information will comply with law.
(g)
The Company will make generally
available to its security holders, as soon as it is practicable to
do so, but in any event not later than 15 months after the date
hereof, an earning statement (which need not be audited) in
reasonable detail, covering a period of at least 12 consecutive
months beginning after the date hereof, which earnings statement
shall satisfy the requirements of Section 11(a) of the
Act and Rule 158 of the Rules and Regulations and will
advise you in writing when such statement has been so made
available.
(h)
The Company will not, without the
prior written consent of Raymond James &
Associates, Inc., directly or indirectly offer, sell, pledge,
contract to sell (including any short sale), grant any option to
purchase or otherwise dispose of any shares of Common Stock or
enter into any Hedging Transaction (as defined below) relating to
the Common Stock (each of the foregoing referred to as a
“Disposition”), or file any reg